Literature DB >> 10068364

A novel antimicrobial agent joins the battle against resistant bacteria.

R C Moellering.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10068364     DOI： 10.7326/0003-4819-130-2-199901190-00012

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

1.  Nationwide German multicenter study on prevalence of antibiotic resistance in staphylococcal bloodstream isolates and comparative in vitro activities of quinupristin-dalfopristin.

Authors:  C von Eiff; R R Reinert; M Kresken; J Brauers; D Hafner; G Peters
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

2.  Ribosomal Resistance: Emerging Problems and Potential Solutions.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-12       Impact factor: 3.663

Review 3.  Oxazolidinones: a review.

Authors:  D I Diekema; R N Jones
Journal:  Drugs       Date:  2000-01       Impact factor: 11.431

Review 4.  Economic impact of antimicrobial resistance.

Authors:  J E McGowan
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

Review 5.  Opinion: the clinical use of selective digestive decontamination.

Authors:  M H Kollef
Journal:  Crit Care       Date:  2000-10-02       Impact factor: 9.097

Review 6.  Antibiotics: From the Beginning to the Future: Part 1.

Authors:  Nancy Khardori; Cecilia Stevaux; Kathryn Ripley
Journal:  Indian J Pediatr       Date:  2019-11-11       Impact factor: 5.319
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.